BLENREP
Live / Registered — Registered (as of 20 Aug 2024)
What this means for you
Registered since 20 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98155191
- Registration number
- 7480629
- Mark type
- Stylized text
- Filed
- 29 Aug 2023
- Published for opposition
- 04 Jun 2024
- Registered
- 20 Aug 2024
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for treatment of oncological diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 20 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jun 2024 — PUBLISHED FOR OPPOSITION
- 15 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 26 Mar 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Mar 2024 — NON-FINAL ACTION E-MAILED
- 26 Mar 2024 — NON-FINAL ACTION WRITTEN
- 25 Mar 2024 — ASSIGNED TO EXAMINER
- 26 Sept 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 01 Sept 2023 — NEW APPLICATION ENTERED